Mineralys Therapeutics, Inc. (MLYS) Stock price, Description, News & Info

#Thinksabio latest news

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need